spacer
home > ict > summer 2019 > the patient journey
PUBLICATIONS
International Clinical Trials

The Patient Journey





One of the most notable changes in the pharmaceutical industry over the past 10 years is the market shift towards implementing patient-centric practices, programmes, and initiatives as patients are empowered to become more knowledgeable and involved in their treatment. As a result, many life sciences companies are adapting to revolve around the patient at every step of the product lifecycle. This shift from product centricity to patient centricity is moving at varying rates, but it is generally agreed that better patient centricity results in better business and patient outcomes (1).

‘Patient centricity’ can be thought of as the process of designing a product, service, or solution around the patient. In reference to medical products, patient centricity is often the focus during clinical development, with the safety and outcome of every patient in a clinical trial being paramount. During post-approval, the focus is distributed across payers, healthcare providers, regulators, and other company stakeholders. Building patient centricity into every phase of the drug development process requires a comprehensive approach that draws upon numerous stakeholders within the healthcare ecosystem.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
About the author


Susan Najjar has over 25 years of industry experience with several years in senior leadership and consulting positions. Prior to joining Sciformix, a Covance company, Susan oversaw global marketing activities for Thermo Fisher Scientific’s informatics division, developing growth strategies and implementing innovative marketing programmes. Prior to Thermo, she was accountable for establishing the Gillette Company’s North American Blades and Razors forecasting and planning, executing software product launches at Sun Microsystems, and consulting senior pharma executive teams at Deloitte & Touche. Susan has an MS in Biochemical Engineering from Tufts University, US, and an MBA from MIT Sloan, US.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma Celebrates 15 Years of Growth and Success

Vilnius, Lithuania, July 16, 2019 ─ Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company focuses on understanding its customers and meeting their specific needs without binding them to one single approach. It is able to react rapidly to unexpected project changes, adjusting timelines, capacities and other activities to meet its customers’ evolving needs. On average, Northway Biotechpharma has 25–30 development projects underway each year, ranging from gene cloning to final drug product manufacturing.
More info >>

White Papers

Role of Comparators in Clinical Trial Supply

Clinical Services International

CSI analyses the role of comparators in different trial designs and offers expert advice on robust methodology for choosing the most appropriate comparators. Case studies provide real insight on how to choose comparators for rare diseases and oncology studies.
More info >>

 
Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement